A non-recourse stock loan can limit the lender’s recovery of the loan to agreed collateral. Assessing the safety of the arrangement also requires a clear understanding of how it is funded, what rights exist over the shares and how each party will perform its obligations.
Those questions can be examined before proceeding. The aim is to establish what the protections actually cover and whether the remaining risks are acceptable for the borrower’s circumstances.
Understand the funding arrangements
Establish where the funding will be held, what evidence will confirm it and the conditions for its release. If capital is prefunded, understand the amount covered and how it relates to the proposed advance.
The order of the steps matters. If collateral is delivered before the funding is in place, the borrower has parted with control of the shares while the lender’s obligation is still unperformed. Prefunding reverses that order for the approved advance.
At Silo, capital for approved financing is deposited into an account opened in the borrower’s name at the designated licensed broker-dealer before the corresponding shares are deposited. The borrower can verify the capital in place, with release subject to the agreed settlement conditions. Ongoing collateral rights and return obligations are addressed separately in the agreements.
Assess the brokerage arrangement
The lender, broker-dealer and any underlying custody institutions may have different roles. Establish which entity maintains the account, who can give instructions, what reporting the borrower receives and how collateral movements are authorized.
An account in the borrower’s name is one fact to verify. The associated agreements determine the rights over the assets. The institution’s exact legal identity and relevant regulatory permissions should also be checked independently through the appropriate official register.
For a financing arrangement that requires a designated broker-dealer, the borrower needs enough information to assess that institution and its role. Familiarity with a name is only one part of that assessment.
Read the rights over the shares
Non-recourse describes the lender’s recovery rights. It does not establish whether the collateral can be transferred, lent or reused during the term. Any such permissions, their limits and the return obligation should be clear in the transaction documents.
Read the full document set together. A useful review addresses ownership, permitted collateral use, valuation, enforcement and the obligation to return securities after repayment. Where the structure allows onward use, the borrower should also understand the resulting exposure to the parties required to perform.
Understand the events that change the position
The agreements should explain what happens if the share price declines, an obligation is not met or another contractual trigger occurs. Some events may allow a remedy within an agreed period; others may permit enforcement without a cure. The applicable terms matter more than a general assurance that the facility is non-recourse.
Costs, repayment conditions, governing law and dispute-resolution provisions should be understood before signing. The borrower’s advisers can assess how those provisions operate together and in the relevant jurisdictions.
Consider evidence of performance
Ask what relevant transaction experience can be substantiated. A proposed facility limit is different from money actually advanced. Funding history and, where available, evidence of completed repayment and collateral return address different parts of the lender’s performance.
Historical experience is useful context. It does not remove the need to assess the particular counterparty, documents and proposed transaction.
How Silo approaches these questions
Silo lends as principal. The designated broker-dealer forms part of its financing and settlement process; its identity and credentials are provided privately after completion of client due diligence and KYC. Full transaction drafts are provided to the borrower’s counsel before signing.
Each proposal is assessed individually. Funding requires Silo’s approval, and the agreements expressly address permitted collateral use and the conditions for repayment and return.
Frequently asked questions
What determines whether a non-recourse stock loan is safe?
Non-recourse limits the lender’s recovery of the loan to the agreed collateral. Whether the arrangement as a whole is safe depends on how it is funded, who maintains the account and under what agreements, what rights exist over the shares during the term, and what happens if the share price declines or an obligation is not met. Each of those can be examined before proceeding.
Should I verify the broker-dealer myself?
Yes. An account in the borrower’s name is one fact to verify; the associated agreements determine the rights over the assets. The institution’s exact legal identity and relevant regulatory permissions should be checked independently through the appropriate official register.
Can the lender sell, lend or reuse my shares during the term?
Non-recourse does not answer that question. Any permission to transfer, lend or reuse collateral, its limits and the obligation to return securities after repayment should be clear in the transaction documents, which should be read together before signing.
Discuss a proposed facility
Share the issuer, exchange, size of the shareholding and financing objective with Silo to begin an assessment. The proposed structure and its requirements can then be considered through the private diligence process.
This material is provided for informational purposes only. Nothing herein constitutes investment, legal, tax, securities, accounting or regulatory advice, an offer to lend or provide financing, a solicitation, a recommendation, or a commitment to enter into any transaction. Securities-backed financing involves risk, including loss of collateral. Past transactions do not establish the amount, timing or availability of future financing. Access may be restricted by jurisdiction or residency. Any potential facility remains subject to Silo’s review, diligence, approval, jurisdictional analysis, compliance review and definitive documentation. Readers should consult their own professional advisers.